French startup E(ye)Brain, in collaboration with neurologists at La Pitié-Salpêtrière Hospital in Paris, has been working on a video-oculography measurement technology for early diagnosis of neurological diseases. The company has recently announced that its Mobile Eye Brain Tracker will soon be hitting the market, probably in Europe and elsewhere, except for the United States where no FDA clearance has been given to the device. The company hopes that its technology will be validated for early diagnosis in a range of disorders, such as progressive supranuclear palsy, corticobasal degeneration, multiple sclerosis, and even Parkinson’s.
For clinical use, the MOBILE EBT, a certified CE IIa medical device, provides simple, automatic eye movement examinations using:
– a set of predefined visual stimuli
– automatic eye movement analysis
– automatic clinical report printouts of complete eye movement exam results
Main features of the MOBILE EBT:
– adjustable structure fits any patient
– quick, precise eye tracker
– fully binocular measurement (2 x 300 Hz)
– CE marked for clinical use
– computer application including visual and auditory stimuli
– computer application for eye movement analysis
Main visual stimuli included:
– horizontal pro-saccades
– vertical pro-saccades
– anti-saccades
– horizontal pursuit fixations (flutter, square waves)
Main visual stimuli included:Product page: e(ye)BRAIN …
Press release: EyeBrain launches eye-tracking device for diagnosis of Parkinson-plus diseases …